GSK is a global British biopharmaceutical company formed in 2000 via the merger of Glaxo Wellcome and SmithKline Beecham. It focuses on vaccines and specialty medicines for respiratory, HIV, oncology, infectious and immunological conditions. With operations in 75+ countries, GSK invested £6.4 billion in R&D in 2024, delivering medicines to over 2 billion people and achieving £31.4 billion revenue. Consistently ranked #1 on the Access to Medicine Index, it’s committed to innovation, sustainable chemistry, and ambitious global impact goals.
0 products